The global vitreous tamponades market was valued at US$ 77.2 Mn in 2017 and expected to reach US$ 105.8 Mn by 2026, expanding at a CAGR of 3.5% from 2018 to 2026.
Market Insights
Vitreous tamponades are used in vitrectomy surgeries for reattachment of the retina and treatment of other vitreous deformations. These products are often used for the treatment of retinal disorders during retinal surgery and post-surgery recovery measure. Some of the common conditions where vitreous tamponades are sued during treatment are retinitis pigmentosa, diabetic retinopathy, retinal degeneration, retinal detachment, macular hole, macular edema, retinopathy of prematurity, uveitis, vascular occlusion and so on. Vitreous occupies the gap between the eye lens and the retina; and since it cannot regenerate, this cavity needs to be refilled with substitute through surgery. Gas and liquid vitreous tamponades are the ideal choices during surgical interventions.
Stable growth of the global vitreous tamponades market is driven by an increasing incidence of retinal conditions such as diabetic retinopathy, retinal detachments, etc. the global incidence of diabetes is increasing, thereby paving way for an increased patient pool for diabetic retinopathy, consequently increasing the demand for vitreous tamponades in vitrectomy.
Ongoing developments in the field of vitreoretinal surgery have also augmented the need for appropriate vitreous substitutes. An ideal substitute is expected to maintain all the biochemical and physical characteristics of the natural vitreous. Furthermore, as new surgical techniques with smaller instruments have been introduced in the market with proven safety profiles, there has been a consistent growth in the number of patients opting for such surgeries. This has also led to the use of more viscous vitreous substitutes.
The growing incidence of vitreoretinal disorders and diabetes complications such as diabetic retinopathy is a key driver of this market. These conditions are treated with vitrectomy which involves removal of the vitreous humor along with replacement with a synthetic substitute. Additionally, increasing geriatric population is also considered as one of the prominent factors positively impacting market growth. Based on the competitive scenario, this market is witnessing the presence of a limited number of players, which further enjoy regional dominance.
Key Market Movements
This product will be delivered within 2 business days.
Market Insights
Vitreous tamponades are used in vitrectomy surgeries for reattachment of the retina and treatment of other vitreous deformations. These products are often used for the treatment of retinal disorders during retinal surgery and post-surgery recovery measure. Some of the common conditions where vitreous tamponades are sued during treatment are retinitis pigmentosa, diabetic retinopathy, retinal degeneration, retinal detachment, macular hole, macular edema, retinopathy of prematurity, uveitis, vascular occlusion and so on. Vitreous occupies the gap between the eye lens and the retina; and since it cannot regenerate, this cavity needs to be refilled with substitute through surgery. Gas and liquid vitreous tamponades are the ideal choices during surgical interventions.
Stable growth of the global vitreous tamponades market is driven by an increasing incidence of retinal conditions such as diabetic retinopathy, retinal detachments, etc. the global incidence of diabetes is increasing, thereby paving way for an increased patient pool for diabetic retinopathy, consequently increasing the demand for vitreous tamponades in vitrectomy.
Ongoing developments in the field of vitreoretinal surgery have also augmented the need for appropriate vitreous substitutes. An ideal substitute is expected to maintain all the biochemical and physical characteristics of the natural vitreous. Furthermore, as new surgical techniques with smaller instruments have been introduced in the market with proven safety profiles, there has been a consistent growth in the number of patients opting for such surgeries. This has also led to the use of more viscous vitreous substitutes.
The growing incidence of vitreoretinal disorders and diabetes complications such as diabetic retinopathy is a key driver of this market. These conditions are treated with vitrectomy which involves removal of the vitreous humor along with replacement with a synthetic substitute. Additionally, increasing geriatric population is also considered as one of the prominent factors positively impacting market growth. Based on the competitive scenario, this market is witnessing the presence of a limited number of players, which further enjoy regional dominance.
Key Market Movements
- The increasing pool of the diabetic population, therefore increasing the patient count for diabetic retinopathy
- Improvement in surgical methods and technologies attracting even more patients opting for vitreoretinal surgeries
- Growing awareness in the general population and improving healthcare infrastructure in the Asia Pacific market
- Perpetual growth in the prevalence of diabetes in key areas such as India and China
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Preface
Chapter 2. Executive Summary
Chapter 3. Global Vitreous Tamponades Market: Dynamics and Future Outlook
Chapter 4. Global Vitreous Tamponades Market, by Type, 2016 - 2026 (US$ Mn)
Chapter 5. Global Vitreous Tamponades Market, by Geography, 2016 – 2026 (US$ Mn)
Chapter 6. Company Profiles
List of Figures
List of Tables
Companies Mentioned
- Carl Zeiss Meditec AG
- Dutch Ophthalmic Research Center (International) B.V.
- AL.CHI.MI.A Srl
- Valeant Pharmaceuticals International, Inc.
- Fluoron GmbH
- Novartis AG
- Alcon, Inc.
- Croma-Pharma GmbH
- Arcadophta
